<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Polymorphisms in Turkish population &#187; gene</title>
	<atom:link href="http://polymorphisms.info/tag/gene/feed" rel="self" type="application/rss+xml" />
	<link>http://polymorphisms.info</link>
	<description></description>
	<lastBuildDate>Thu, 19 May 2011 20:57:51 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>677C&gt;T and 1298A&gt;C Polymorphisms of Methylenetetrahydropholate Reductase Gene and Biochemical Parameters in Turkish Population with Spina Bifida Occulta.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:40:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Methylenetetrahydropholate Reductase]]></category>
		<category><![CDATA[Aslan]]></category>
		<category><![CDATA[Biochemical]]></category>
		<category><![CDATA[Buyukbas]]></category>
		<category><![CDATA[C MTHFR]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[erdogan]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[folate]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[homocysteine]]></category>
		<category><![CDATA[homozygosity]]></category>
		<category><![CDATA[M. Selcuk]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Meram]]></category>
		<category><![CDATA[Methylenetetrahydropholate]]></category>
		<category><![CDATA[Neurosurg]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[serum]]></category>
		<category><![CDATA[Solak]]></category>
		<category><![CDATA[Turk]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[vitamin]]></category>
		<category><![CDATA[Yildiz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=296</guid>
		<description><![CDATA[Turk Neurosurg. 2010 Jan;20(1):9-15.
Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M.
Selcuk University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey.

AIM: This study aimed to investigate the 677C &#62; T and 1298A &#62; C MTHFR gene polymorphisms and their metabolic effects on the levels [...]]]></description>
			<content:encoded><![CDATA[<p>Turk Neurosurg. 2010 Jan;20(1):9-15.</p>
<p>Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M.</p>
<p>Selcuk University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey.</p>
<div>
<p>AIM: This study aimed to investigate the 677C &gt; T and 1298A &gt; C MTHFR gene polymorphisms and their metabolic effects on the levels of folate, vitamin B12 and homocysteine in the serum of Turkish spina bifida occulta (SBO) patients and healthy individuals in disease. MATERIAL and METHODS: A case-control study was performed to detect 677C &gt; T and 1298A &gt; C MTHFR gene polymorphisms in 39 SBO patients and 34 healthy individuals. The folate, vitamin B12 and homocysteine concentrations in the serum of SBO and healthy individuals were evaluated and compared with MTHFR gene polymorphisms. RESULTS: 677 CC/CT/TT MTHFR genotype frequency differences between the SBO patients and controls were not significant (x(2)=3.325, P=0.068; x(2)=1.479, P=0.224; x(2)=0.275, P=0.600; respectively). 1298A &gt; C MTHFR genotype frequency differences between the SBO patients and controls were significant (x(2)=8.477, P=0.004). The frequencies of the Aand C alleles of the 1298A &gt; C polymorphism did not differ in a statistically significant manner between the groups (x(2)=0.576, P=0.448). The biochemical parameters were not significantly different between SBO patients and healthy individuals (P &gt; 0.05). CONCLUSION: The 677C &gt; T and 1298A &gt; C polymorphisms of the MTHFR gene cannot be regarded as major risk factors for SBO in the Turkish patients 677TT homozygosity may affect the metabolism of homocysteine.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Angiotensin-Converting Enzyme Gene Polymorphism in Overweight and Obese Turkish Patients with Insulin Resistance.</title>
		<link>http://polymorphisms.info/polymorphisms/angiotensin-converting-enzyme-gene-polymorphism-in-overweight-and-obese-turkish-patients-with-insulin-resistance.html</link>
		<comments>http://polymorphisms.info/polymorphisms/angiotensin-converting-enzyme-gene-polymorphism-in-overweight-and-obese-turkish-patients-with-insulin-resistance.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:37:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[ACE]]></category>
		<category><![CDATA[amplification]]></category>
		<category><![CDATA[Angiotensin]]></category>
		<category><![CDATA[Bastemir]]></category>
		<category><![CDATA[Biol]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[control]]></category>
		<category><![CDATA[Converting]]></category>
		<category><![CDATA[deletion]]></category>
		<category><![CDATA[Denizli]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[enzyme]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[gene polymorphism]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Guclu]]></category>
		<category><![CDATA[Karasu]]></category>
		<category><![CDATA[Kursunluoglu]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[metabolism]]></category>
		<category><![CDATA[Overweight]]></category>
		<category><![CDATA[Pamukkale]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[reaction]]></category>
		<category><![CDATA[resistance]]></category>
		<category><![CDATA[Turgut]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=293</guid>
		<description><![CDATA[DNA Cell Biol. 2010 Jan 13.
Akin F, Turgut S, Bastemir M, Turgut G, Kursunluoglu R, Karasu U, Guclu A.
1 Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University , Denizli, Turkey .

The aim of this study was to analyze the distribution of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in obese [...]]]></description>
			<content:encoded><![CDATA[<p>DNA Cell Biol. 2010 Jan 13.</p>
<p>Akin F, Turgut S, Bastemir M, Turgut G, Kursunluoglu R, Karasu U, Guclu A.</p>
<p>1 Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University , Denizli, Turkey .</p>
<div>
<p>The aim of this study was to analyze the distribution of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in obese Turkish patients with insulin resistance (IR). Sixty-two obese Turkish patients with IR were enrolled in this study. One hundred healthy people without IR were recruited as the control group. ACE amplification was performed by polymerase chain reaction. The frequency of the DD genotype was significantly higher in obese patients with IR than in control subjects. Of sixty-two patients, 1 (1.6%) had an II genotype, 22 (35.5%) had an ID genotype, and 39 (62.9%) had a DD genotype. The frequency of the I allele in the patient group was significantly lower than in controls. We found that the frequency of the DD genotype was higher in obese Turkish patients with IR. ACE gene I/D polymorphism may be associated with obesity in the Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/polymorphisms/angiotensin-converting-enzyme-gene-polymorphism-in-overweight-and-obese-turkish-patients-with-insulin-resistance.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey</title>
		<link>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html#comments</comments>
		<pubDate>Wed, 20 Jan 2010 23:47:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Interleukin]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[Activation]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[Biol]]></category>
		<category><![CDATA[Biological]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[fragment length polymorphism]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[gene promoter]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Genotypes]]></category>
		<category><![CDATA[Genotyping]]></category>
		<category><![CDATA[homozygote]]></category>
		<category><![CDATA[Human]]></category>
		<category><![CDATA[Humans]]></category>
		<category><![CDATA[Ozbey]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[promoter region]]></category>
		<category><![CDATA[Psychiatric]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction fragment]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[schizophrenic patients]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[turkish population]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=286</guid>
		<description><![CDATA[Author(s): Ozbey U (Ozbey, Ulku)2, Tug E (Tug, Esra)1, Namli M (Namli, Mustafa)3
Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY Volume: 10 Issue: 5 Pages: 461-468 Published: 2009
Abstract: Schizophrenia is one of the most severe psychiatric disorders, with a worldwide incidence of 1%. Immunological abnormalities have been found to be associated with schizophrenia for decades. Cytokines are [...]]]></description>
			<content:encoded><![CDATA[<p>Author(s): Ozbey U (Ozbey, Ulku)2, Tug E (Tug, Esra)1, Namli M (Namli, Mustafa)3<br />
Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY Volume: 10 Issue: 5 Pages: 461-468 Published: 2009</p>
<p><strong>Abstract:</strong> Schizophrenia is one of the most severe psychiatric disorders, with a worldwide incidence of 1%. Immunological abnormalities have been found to be associated with schizophrenia for decades. Cytokines are key proteins involved in the immune system activation. Interleukin-10 (IL-10), an important immunoregulatory cytokine, is located on chromosome 1q31 32, a region previously reported to be linked to schizophrenia in genetic studies. In the present study it was aimed to examine the IL-10 gene promoter region&#8217;s polymorphic variants in patients with schizophrenia in a population of the Elazig Region of East Anatolia, Turkey. Polymorphisms at position -1082, -819 and -592 in the IL-10 promoter region were determined in 171 Turkish patients who were diagnosed with schizophrenia, based on the DSM-IV, and 168 healthy controls, by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). We analyzed allele, genotype, and haplotype distributions using a case-control association study. Genotyping was performed by RFLP. Statistically significant differences were observed in both allelic and genotypic frequencies of the -592A/C polymorphism (Allele, P = 0.034, OR = 1.26, 95% CI 1.02 &#8211; 1.56; Genotype, P = 0.048), while the other two polymorphisms in distribution of the alleles and genotypes in patients with schizophrenia were not significantly different from those of controls (P &gt; 0.05). Our results show a significant increase of GTA homozygotes (the high IL-10-producing haplotype) in schizophrenic patients compared to control subjects (P = 0.0001). These data suggest that the IL-10 gene promoter polymorphism may be one of the susceptibility factors to develop schizophrenia in the Turkish population, and apparently in all humans.<br />
Document Type: Article<br />
Language: English<br />
Author Keywords: Biological psychiatry; cytokines; genetics; polymorphism; schizophrenia<br />
KeyWords Plus: ASSOCIATION; HAPLOTYPES; POPULATION; LINKAGE<br />
Reprint Address: Tug, E (reprint author), Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Med Genet, TR-14280 Bolu, Turkey<br />
Addresses:<br />
1. Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Med Genet, TR-14280 Bolu, Turkey<br />
2. Firat Univ, Fac Med, Dept Med Biol &amp; Genet, TR-23169 Elazig, Turkey<br />
3. Hosp Psychiat, Elazig, Turkey<br />
E-mail Addresses: esratug@hotmail.com</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novel GDAP1 Mutation in a Turkish Family with CMT2K (CMT2K with Novel GDAP1 Mutation).</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/novel-gdap1-mutation-in-a-turkish-family-with-cmt2k-cmt2k-with-novel-gdap1-mutation.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/novel-gdap1-mutation-in-a-turkish-family-with-cmt2k-cmt2k-with-novel-gdap1-mutation.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:42:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[autosomal]]></category>
		<category><![CDATA[axonal]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Calapoglu]]></category>
		<category><![CDATA[chromosome]]></category>
		<category><![CDATA[CMT]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[Cunur]]></category>
		<category><![CDATA[Demirel]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[generation]]></category>
		<category><![CDATA[Isparta]]></category>
		<category><![CDATA[Marie-Tooth]]></category>
		<category><![CDATA[Med]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[missense]]></category>
		<category><![CDATA[mutation]]></category>
		<category><![CDATA[mutations]]></category>
		<category><![CDATA[Neuromolecular]]></category>
		<category><![CDATA[nilufersahin]]></category>
		<category><![CDATA[novel]]></category>
		<category><![CDATA[Ozcelik]]></category>
		<category><![CDATA[presence]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[region]]></category>
		<category><![CDATA[Sahin]]></category>
		<category><![CDATA[splice]]></category>
		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=232</guid>
		<description><![CDATA[Neuromolecular Med. 2009 Apr 19.

Sahin-Calapoglu N, Tan M, Soyoz M, Calapoglu M, Ozcelik N.
Department of Medical Biology, Faculty of Medicine, Suleyman Demirel University, 32260 Cunur, Isparta, Turkey, nilufersahin@yahoo.com.
Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause Charcot-Marie-Tooth type 2 (CMT2), a severe autosomal recessive form of neuropathy associated with axonal phenotypes. It has been [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Neuromolecular medicine."><a href="javascript:AL_get(this, 'jour', 'Neuromolecular Med.');">Neuromolecular Med.</a></span> 2009 Apr 19.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Sahin-Calapoglu%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Sahin-Calapoglu N</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Tan%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Tan M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Soyoz%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Soyoz M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Calapoglu%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Calapoglu M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozcelik%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozcelik N</strong></a>.</div>
<p class="affiliation">Department of Medical Biology, Faculty of Medicine, Suleyman Demirel University, 32260 Cunur, Isparta, Turkey, nilufersahin@yahoo.com.</p>
<p class="abstract">Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause Charcot-Marie-Tooth type 2 (CMT2), a severe autosomal recessive form of neuropathy associated with axonal phenotypes. It has been screened in this study for the presence of mutations in the coding region of GDAP1, which maps to chromosome 8q21, in a family with CMT2. To date, 29 mutations in the GDAP1 have been reported in patients of different ethnic origins. Here, we report a novel missense mutation (c.836A&gt;G), and two polymorphisms: a silent variant (c.102G&gt;C), and a 5&#8242;-splice site mutation (IVS5+24C&gt;T) in GDPA1 gene identified in a five generation Turkish family with autosomal recessive CMT2.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/novel-gdap1-mutation-in-a-turkish-family-with-cmt2k-cmt2k-with-novel-gdap1-mutation.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/genotype-and-allele-frequencies-of-mdr1-gene-c1236t-polymorphism-in-a-turkish-population.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/genotype-and-allele-frequencies-of-mdr1-gene-c1236t-polymorphism-in-a-turkish-population.html#comments</comments>
		<pubDate>Tue, 09 Dec 2008 21:47:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[allele frequencies]]></category>
		<category><![CDATA[ankara turkey]]></category>
		<category><![CDATA[ankara university]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[biology faculty]]></category>
		<category><![CDATA[chromosomal]]></category>
		<category><![CDATA[clinical impact]]></category>
		<category><![CDATA[faculty of medicine]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[genotype frequencies]]></category>
		<category><![CDATA[glycoprotein]]></category>
		<category><![CDATA[indian populations]]></category>
		<category><![CDATA[length]]></category>
		<category><![CDATA[medical biology]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[nucleotide polymorphisms]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[pharmacokinetic studies]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[polymerase chain reaction pcr]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[relevance]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[restriction fragment length polymorphism]]></category>
		<category><![CDATA[RFLP]]></category>
		<category><![CDATA[substrate]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[university ankara]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=183</guid>
		<description><![CDATA[Genet Mol Res. 2008 Oct 28;7(4):1193-9. 

Gümüŝ-Akay G, Rüstemoğlu A, Karadağ A, Sunguroğlu A.
Department of Medical Biology, Faculty of Medicine, Ankara University, Ankara, Turkey guvemg@yahoo.com.
Human P-glycoprotein (P-gp) is encoded by the MDR1 gene, which is located on chromosomal region 7q21 and consists of 28 exons. To date, over 50 single nucleotide polymorphisms (SNPs) have been [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Genetics and molecular research : GMR."><a href="javascript:AL_get(this, 'jour', 'Genet Mol Res.');">Genet Mol Res.</a></span> 2008 Oct 28;7(4):1193-9.<span class="linkbar"><script></script> </span></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22G%C3%BCm%C3%BC%C5%9D-Akay%20G%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Gümüŝ-Akay G</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22R%C3%BCstemo%C4%9Flu%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Rüstemoğlu A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Karada%C4%9F%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Karadağ A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Sunguro%C4%9Flu%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Sunguroğlu A</strong></a>.</div>
<p class="affiliation">Department of Medical Biology, Faculty of Medicine, Ankara University, Ankara, Turkey guvemg@yahoo.com.</p>
<p class="abstract">Human P-glycoprotein (P-gp) is encoded by the MDR1 gene, which is located on chromosomal region 7q21 and consists of 28 exons. To date, over 50 single nucleotide polymorphisms (SNPs) have been reported for the MDR1 gene. The effect of these polymorphisms on P-gp function or their clinical impact is in most cases unknown, but some of the SNPs are known to be of functional relevance and can also alter the pharmacokinetics of substrate drugs. The aim of the current study was to analyze for the first time an existing silent MDR1 C1236T (Gly412Gly) polymorphism in a Turkish population. The genotype frequencies of C1236T SNP in a Turkish population were also compared with those in other populations. One hundred unrelated healthy subjects (48 females, 52 males) were included in this study and all them were of Turkish ethnicity. The genotyping of the C1236T SNP was performed by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method. The frequencies of the wild-type C and mutant T alleles were 45.5 and 54.5%, respectively. The distribution of C1236T genotype frequencies in our study group was found to be similar to that in Czech, Polish, Portuguese, Russian, Malay, and Japanese populations and different from that in French, German, Chinese, and Indian populations. The distributions of CC, CT, and TT genotypes were 20.0, 51.0, and 29.0%, respectively. Our study provides a framework for future studies concerning the role of polymorphic variants of MDR1 gene in the genesis of various diseases or in designing future pharmacogenetic and pharmacokinetic studies conducted with P-gp substrates in the Turkish population.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/genotype-and-allele-frequencies-of-mdr1-gene-c1236t-polymorphism-in-a-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.</title>
		<link>http://polymorphisms.info/cancer-kanser/thyroid-cancer-tiroid-kanseri/interleukin-10-gene-polymorphism-in-patients-with-papillary-thyroid-cancer-in-turkish-population.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/thyroid-cancer-tiroid-kanseri/interleukin-10-gene-polymorphism-in-patients-with-papillary-thyroid-cancer-in-turkish-population.html#comments</comments>
		<pubDate>Thu, 04 Dec 2008 23:08:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Thyroid cancer(Tiroid kanseri)]]></category>
		<category><![CDATA[allelic frequencies]]></category>
		<category><![CDATA[Berdeli]]></category>
		<category><![CDATA[biological role]]></category>
		<category><![CDATA[Bornova]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chronic]]></category>
		<category><![CDATA[chronic inflammation]]></category>
		<category><![CDATA[control groups]]></category>
		<category><![CDATA[cytokine]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DESIGN]]></category>
		<category><![CDATA[difference]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[drmerdogan]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[endocrinology and metabolism]]></category>
		<category><![CDATA[factor]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[germ line]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[inflammatory response]]></category>
		<category><![CDATA[interleukin 10]]></category>
		<category><![CDATA[Izmir]]></category>
		<category><![CDATA[izmir turkey]]></category>
		<category><![CDATA[J Endocrinol]]></category>
		<category><![CDATA[Karadeniz]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[metabolism]]></category>
		<category><![CDATA[Methods]]></category>
		<category><![CDATA[ozbek]]></category>
		<category><![CDATA[Ozgen]]></category>
		<category><![CDATA[papillary thyroid cancer]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[population research]]></category>
		<category><![CDATA[proinflammatory]]></category>
		<category><![CDATA[PTC]]></category>
		<category><![CDATA[regulation]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[thyroid]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[university medical school]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=179</guid>
		<description><![CDATA[ 
 J Endocrinol Invest. 2008 Sep;31(9):750-4.

Erdogan M, Karadeniz M, Ozbek M, Ozgen AG, Berdeli A.
Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, Izmir, Turkey. drmerdogan61@yahoo.com
OBJECTIVE: Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that plays a crucial role in the regulation of the immune system. Chronic inflammation has been reported to be a [...]]]></description>
			<content:encoded><![CDATA[<p> </p>
<p><strong> </strong><span title="Journal of endocrinological investigation."><a href="javascript:AL_get(this, 'jour', 'J Endocrinol Invest.');">J Endocrinol Invest.</a></span> 2008 Sep;31(9):750-4.<script></script></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Erdogan%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Erdogan M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Karadeniz%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Karadeniz M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozbek%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozbek M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozgen%20AG%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozgen AG</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Berdeli%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Berdeli A</strong></a>.</div>
<p class="affiliation">Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, Izmir, Turkey. drmerdogan61@yahoo.com</p>
<p class="abstract">OBJECTIVE: Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that plays a crucial role in the regulation of the immune system. Chronic inflammation has been reported to be a risk factor for thyroid neoplasia. The propensity to mount an inflammatory response is modified by germ line variation in cytokine and other inflammation-related genes. We hypothesized that a proinflammatory genotype would be positively associated with thyroid cancer. We aimed to evaluate the relation between the genotypic and allelic frequencies of the IL-10(-1082 G/A), IL-10(-592 A/C), and IL-10(-819 C/T) polymorphisms, and their association with the risk of developing papillary thyroid cancer (PTC) in the Turkish population. RESEARCH DESIGN AND METHODS: Forty-two patients with PTC and 113 healthy controls were included in this study. The diagnosis of PTC was confirmed by histopathologic examination after surgery. The evaluation of genotype for IL-10 gene polymorphism was performed using PCR-restriction fragment length polymorphism method. RESULTS: Statistically significant difference IL-10(-1082 G/A) gene polymorphism was determined between 2 (PTC and control) groups. No difference was determined with respect to IL-10(-592 A/C) and IL-10(-819 C/T) gene polymorphisms, and IL-10(-1082 G/A), IL-10(-592 A/C), and IL-10(-819 C/T) allele frequencies of participating between the control group and the patients with PTC (p&gt;0.05). CONCLUSIONS: The polymorphism of IL-10(-1082 G/A) gene was significantly associated with the occurrence of PTC. Such studies will contribute significantly to our understanding of the biological role of IL-10(-1082 G/A) gene polymorphism in PTC development. In conclusion, IL-10(-1082 G/A) gene polymorphism may affect the survival of papillary thyroid carcinoma.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/thyroid-cancer-tiroid-kanseri/interleukin-10-gene-polymorphism-in-patients-with-papillary-thyroid-cancer-in-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Association of Genetic Polymorphisms in Vitamin D Receptor Gene and Susceptibility to Sporadic Prostate Cancer.</title>
		<link>http://polymorphisms.info/cancer-kanser/prostate-cancer-prostat-kanseri/association-of-genetic-polymorphisms-in-vitamin-d-receptor-gene-and-susceptibility-to-sporadic-prostate-cancer.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/prostate-cancer-prostat-kanseri/association-of-genetic-polymorphisms-in-vitamin-d-receptor-gene-and-susceptibility-to-sporadic-prostate-cancer.html#comments</comments>
		<pubDate>Mon, 10 Nov 2008 21:13:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Prostate cancer(Prostat Kanseri)]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[allele frequencies]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[D Receptor]]></category>
		<category><![CDATA[Ekmekci]]></category>
		<category><![CDATA[Epub]]></category>
		<category><![CDATA[eroglu]]></category>
		<category><![CDATA[etiology]]></category>
		<category><![CDATA[exp biol]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[fragment length polymorphism]]></category>
		<category><![CDATA[gazi university faculty]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[genotype frequencies]]></category>
		<category><![CDATA[H. Gazi]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[nucleotide polymorphisms]]></category>
		<category><![CDATA[PCa]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[progression]]></category>
		<category><![CDATA[Prostate]]></category>
		<category><![CDATA[receptor]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[restriction fragment length polymorphism]]></category>
		<category><![CDATA[SNPs]]></category>
		<category><![CDATA[susceptibility]]></category>
		<category><![CDATA[TaqI]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[vitamin]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=177</guid>
		<description><![CDATA[Exp Biol Med (Maywood). 2008 Oct 10. [Epub ahead of print] 

Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H.
Gazi University, Faculty of Medicine.
Genetic and environmental factors are involved in Prostate Cancer (PCa) etiology. Single nucleotide polymorphisms (SNPs) may contribute to the PCa pathogenesis. The goal of this study is to determine [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Experimental biology and medicine (Maywood, N.J.)."><a href="javascript:AL_get(this, 'jour', 'Exp Biol Med (Maywood).');">Exp Biol Med (Maywood).</a></span> 2008 Oct 10. [Epub ahead of print]<span class="featured_linkouts"><a href="http://polymorphisms.info/entrez/utils/fref.fcgi?PrId=3051&amp;itool=AbstractPlus-def&amp;uid=18849534&amp;db=pubmed&amp;url=http://www.ebmonline.org/cgi/pmidlookup?view=long&amp;pmid=18849534" target="_blank"></a> </span><span class="linkbar"><script></script></span></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Onen%20IH%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Onen IH</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ekmekci%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ekmekci A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Eroglu%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Eroglu M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Konac%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Konac E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yesil%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yesil S</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Biri%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Biri H</strong></a>.</div>
<p class="affiliation">Gazi University, Faculty of Medicine.</p>
<p class="abstract" style="text-align: left;">Genetic and environmental factors are involved in Prostate Cancer (PCa) etiology. Single nucleotide polymorphisms (SNPs) may contribute to the PCa pathogenesis. The goal of this study is to determine the role of vitamin D receptor (VDR) gene polymorphisms and haplotypes in the development and progression of sporadic PCa. One hundred and thirty-three PCa patients and one hundred and fifty-seven age-matched healthy controls were genotyped for the ApaI (rs7975232), BsmI (rs1544410) and TaqI (rs731236) polymorphisms in VDR gene by using polymerase chain reaction-restriction fragment length polymorphism. An association was observed between the ApaI polymorphism and PCa predisposition (P = 0.03). When compared with AA genotype, there was a highly notable difference in the frequencies of the Aa (P = 0.02), aa (P = 0.026) and ApaI &#8220;a&#8221; allele carriers (Aa+aa) (P = 0.009) genotypes. Furthermore, we found a statistical difference in the allele frequencies of the ApaI polymorphism between the sporadic PCa patients and control subjects (P = 0.013). The genotype distribution for the BsmI and TaqI polymorphisms were similar between cases and controls (P &gt;0.05). No clinically significant relationship was found between the three-locus haplotypes and development of sporadic PCa. The genotype frequencies for the three polymorphisms of the VDR gene within subgroups of PCa (defined by tumor stage, Gleason score, PSA levels) were also analyzed, but no statistically noteworthy difference was observed (P &gt;0.05). As far as we know, this is the first study which investigates the relationship between VDR genotypes and sporadic PCa in the Turkish Population. Our findings suggest that the VDR ApaI (rs7975232) polymorphism may play a role in the development of sporadic PCa.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/prostate-cancer-prostat-kanseri/association-of-genetic-polymorphisms-in-vitamin-d-receptor-gene-and-susceptibility-to-sporadic-prostate-cancer.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations.</title>
		<link>http://polymorphisms.info/polymorphisms/comparison-of-slco1b1-sequence-variability-among-german-turkish-and-african-populations.html</link>
		<comments>http://polymorphisms.info/polymorphisms/comparison-of-slco1b1-sequence-variability-among-german-turkish-and-african-populations.html#comments</comments>
		<pubDate>Fri, 05 Sep 2008 12:27:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[african populations]]></category>
		<category><![CDATA[african subjects]]></category>
		<category><![CDATA[analysis]]></category>
		<category><![CDATA[basis]]></category>
		<category><![CDATA[berlin germany]]></category>
		<category><![CDATA[bile acids]]></category>
		<category><![CDATA[block structure]]></category>
		<category><![CDATA[Epub]]></category>
		<category><![CDATA[extraction]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[gene sequence]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[haplotype]]></category>
		<category><![CDATA[hepatocellular]]></category>
		<category><![CDATA[Humboldt]]></category>
		<category><![CDATA[Institute]]></category>
		<category><![CDATA[J Clin]]></category>
		<category><![CDATA[j clin pharmacol]]></category>
		<category><![CDATA[Köpke]]></category>
		<category><![CDATA[linkage disequilibrium]]></category>
		<category><![CDATA[liver]]></category>
		<category><![CDATA[Methods]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[Pharmacology]]></category>
		<category><![CDATA[portal]]></category>
		<category><![CDATA[RFLP]]></category>
		<category><![CDATA[Roots]]></category>
		<category><![CDATA[Schaefer]]></category>
		<category><![CDATA[Schumannstrasse]]></category>
		<category><![CDATA[sequence]]></category>
		<category><![CDATA[SLCO]]></category>
		<category><![CDATA[SNPs]]></category>
		<category><![CDATA[Universitätsmedizin]]></category>
		<category><![CDATA[xenobiotics]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=175</guid>
		<description><![CDATA[Eur J Clin Pharmacol. 2008 Mar;64(3):257-66. Epub 2008 Jan 6.

Mwinyi J, Köpke K, Schaefer M, Roots I, Gerloff T.
Institute of Clinical Pharmacology, Charité-Universitätsmedizin Berlin, Humboldt University of Berlin, Schumannstrasse 20/21, 10098 Berlin, Germany.
BACKGROUND: OATP1B1 is one of the key hepatocellular uptake transporters providing extraction of diverse compounds, including bile acids, xenobiotics, and a variety of [...]]]></description>
			<content:encoded><![CDATA[<p><span title="European journal of clinical pharmacology."><a href="javascript:AL_get(this, 'jour', 'Eur J Clin Pharmacol.');">Eur J Clin Pharmacol.</a></span> 2008 Mar;64(3):257-66. Epub 2008 Jan 6.<script></script></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Mwinyi%20J%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Mwinyi J</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22K%C3%B6pke%20K%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Köpke K</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Schaefer%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Schaefer M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Roots%20I%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Roots I</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Gerloff%20T%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Gerloff T</strong></a>.</div>
<p class="affiliation">Institute of Clinical Pharmacology, Charité-Universitätsmedizin Berlin, Humboldt University of Berlin, Schumannstrasse 20/21, 10098 Berlin, Germany.</p>
<p class="abstract" style="text-align: justify;">BACKGROUND: OATP1B1 is one of the key hepatocellular uptake transporters providing extraction of diverse compounds, including bile acids, xenobiotics, and a variety of drugs, from portal venous blood into the liver. Polymorphisms of the SLCO1B1 gene have been demonstrated to influence in vitro transport function and the pharmacokinetic profile of compounds. OBJECTIVE: The goal of our study was the comparison of SLCO1B1 gene sequence variability in three ethnic groups as a basis for future genetic association studies. METHODS: Eighteen exonic SLCO1B1 single nucleotide polymorphisms (SNPs) were genotyped by PCR and RFLP analysis in 300 German, 94 Turkish, and 115 African subjects. Calculation of pairwise linkage disequilibrium and estimation of population haplotype frequencies were carried out, and haplotype block structure was determined. RESULTS: Only eight genotyped SNPs (c.388A&gt;G, c.411G&gt;A, c.463C&gt;A, c.521T&gt;C, c.571C&gt;T, c.597C&gt;T, c.1463G&gt;&gt;C, c.1929A&gt;C) were found in at least one of our German, Turkish, or African samples. A total of 12 haplotypes with a frequency &gt;or=1% in at least one of the three populations could be inferred. Between the Caucasian and African samples, significant differences in sequence variability were observed leading to a different haplotype profile in these populations. CONCLUSION: Our results demonstrate a high sequence variability of OATP1B1 within different popuations. In the future, distinct haplotypes should be taken into account when studying the effect of OATP1B1 on drugs in different populations.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/polymorphisms/comparison-of-slco1b1-sequence-variability-among-german-turkish-and-african-populations.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interleukin-1 and tumor necrosis factor-alpha gene polymorphisms in Turkish patients with localized aggressive periodontitis.</title>
		<link>http://polymorphisms.info/polymorphisms/interleukin-1-and-tumor-necrosis-factor-alpha-gene-polymorphisms-in-turkish-patients-with-localized-aggressive-periodontitis.html</link>
		<comments>http://polymorphisms.info/polymorphisms/interleukin-1-and-tumor-necrosis-factor-alpha-gene-polymorphisms-in-turkish-patients-with-localized-aggressive-periodontitis.html#comments</comments>
		<pubDate>Sun, 31 Aug 2008 18:27:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Aggressive periodontitis]]></category>
		<category><![CDATA[Tumor Necrosis Factor]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[amplification]]></category>
		<category><![CDATA[baskent university]]></category>
		<category><![CDATA[Dentistry]]></category>
		<category><![CDATA[digestion]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[enzyme]]></category>
		<category><![CDATA[faculty of dentistry]]></category>
		<category><![CDATA[gel]]></category>
		<category><![CDATA[gel electrophoresis]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Guzeldemir]]></category>
		<category><![CDATA[heterozygosity]]></category>
		<category><![CDATA[homozygosity]]></category>
		<category><![CDATA[Homozygous]]></category>
		<category><![CDATA[immunomodulators]]></category>
		<category><![CDATA[Interleukin]]></category>
		<category><![CDATA[interleukin 1]]></category>
		<category><![CDATA[LAgP]]></category>
		<category><![CDATA[multifactorial]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[Periodontology]]></category>
		<category><![CDATA[prevalence]]></category>
		<category><![CDATA[proinflammatory]]></category>
		<category><![CDATA[proinflammatory cytokines]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[susceptibility]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[turkish population]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=164</guid>
		<description><![CDATA[J Oral Sci. 2008 Jun;50(2):151-9.

Guzeldemir E, Gunhan M, Ozcelik O, Tastan H.
Department of Periodontology, Faculty of Dentistry, Baskent University, Ankara, Turkey. esragd@yahoo.com
Localized aggressive periodontitis (LAgP) is a complex multifactorial periodontal disease to which genetic factors are thought to predispose individuals. Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) are potent immunomodulators and proinflammatory cytokines that have [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Journal of oral science."><a href="javascript:AL_get(this, 'jour', 'J Oral Sci.');">J Oral Sci.</a></span> 2008 Jun;50(2):151-9.<span class="linkbar"><script></script></span></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Guzeldemir%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Guzeldemir E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Gunhan%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Gunhan M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozcelik%20O%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozcelik O</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Tastan%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Tastan H</strong></a>.</div>
<p class="affiliation">Department of Periodontology, Faculty of Dentistry, Baskent University, Ankara, Turkey. esragd@yahoo.com</p>
<p class="abstract" style="text-align: justify;">Localized aggressive periodontitis (LAgP) is a complex multifactorial periodontal disease to which genetic factors are thought to predispose individuals. Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) are potent immunomodulators and proinflammatory cytokines that have been implicated in the pathogenesis of autoimmune and infectious diseases and proposed to be risk factors for LAgP. Our aim was to investigate IL-1 alpha (+4845), IL-1 beta (+3954), and TNF-alpha (-308) gene polymorphisms in Turkish LAgP patients. We genotyped 31 LAgP patients and 31 healthy controls for IL-1alpha(+4845), IL-1beta(+3954), and TNF-alpha(-308) using standard PCR amplification followed by restriction enzyme digestion and gel electrophoresis. Higher prevalence of heterozygosity for IL-1alpha(+4845) was found in cases (65%) when compared to controls (35%) (P &lt; 0.05). While homozygous allele 1 of IL-1beta(+3954) was the most frequent genotype in cases (62%), no controls were homozygous for this allele (P &lt; 0.001). Homozygous allele 1 was the most common TNF-alpha genotype in both groups, however no significant difference in TNF-alpha genotypes was found between groups. In conclusion, in this Turkish population, susceptibility to LAgP is increased by heterozygosity for allele 1 of IL-1alpha(+4845) or homozygosity for allele 1 of IL-1beta(R+3954). Moreover, IL-1 gene polymorphisms appear to have a role in susceptibility to LAgP, and the above-mentioned genotypes could be an important risk factor for LAgP in the Turkish population.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/polymorphisms/interleukin-1-and-tumor-necrosis-factor-alpha-gene-polymorphisms-in-turkish-patients-with-localized-aggressive-periodontitis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Turkish with type 2 diabetes mellitus.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/molecular-scanning-for-mutations-in-the-insulin-receptor-substrate-1-irs-1-gene-in-turkish-with-type-2-diabetes-mellitus.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/molecular-scanning-for-mutations-in-the-insulin-receptor-substrate-1-irs-1-gene-in-turkish-with-type-2-diabetes-mellitus.html#comments</comments>
		<pubDate>Sat, 23 Aug 2008 19:12:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diabetes Mellitus]]></category>
		<category><![CDATA[association]]></category>
		<category><![CDATA[bolu]]></category>
		<category><![CDATA[control patients]]></category>
		<category><![CDATA[Cys]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[diabetic patients]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[dna sequencing]]></category>
		<category><![CDATA[Endocr]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[genetic susceptibility]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Georgetown]]></category>
		<category><![CDATA[georgetown university washington]]></category>
		<category><![CDATA[Human]]></category>
		<category><![CDATA[human genetics]]></category>
		<category><![CDATA[insulin receptor substrate]]></category>
		<category><![CDATA[key role]]></category>
		<category><![CDATA[method]]></category>
		<category><![CDATA[missense mutations]]></category>
		<category><![CDATA[Molecular]]></category>
		<category><![CDATA[mutation]]></category>
		<category><![CDATA[Orkunoglu]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[prevalence]]></category>
		<category><![CDATA[receptor]]></category>
		<category><![CDATA[receptor tyrosine kinase]]></category>
		<category><![CDATA[type 2 diabetes mellitus]]></category>
		<category><![CDATA[Tyr]]></category>
		<category><![CDATA[tyrosine]]></category>
		<category><![CDATA[variant]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=145</guid>
		<description><![CDATA[Endocr J. 2005 Oct;52(5):593-8.

Orkunoglu Suer FE, Mergen H, Bolu E, Ozata M.
Institute for Molecular &#38; Human Genetics, Georgetown University, Washington, DC 20007, USA.
Insulin receptor substrate-1 (IRS-1) is an endogenous substrate for the insulin receptor tyrosine kinase, which plays a key role in insulin signaling. Recent studies have identified several polymorphisms in the human IRS-1 gene [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><span title="Endocrine journal."><a href="javascript:AL_get(this, 'jour', 'Endocr J.');">Endocr J.</a></span> 2005 Oct;52(5):593-8.</p>
<dd class="abstract" style="text-align: justify;">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Orkunoglu%20Suer%20FE%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Orkunoglu Suer FE</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Mergen%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Mergen H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Bolu%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Bolu E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozata%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozata M</strong></a>.</div>
<p class="affiliation">Institute for Molecular &amp; Human Genetics, Georgetown University, Washington, DC 20007, USA.</p>
<p class="abstract" style="text-align: justify;">Insulin receptor substrate-1 (IRS-1) is an endogenous substrate for the insulin receptor tyrosine kinase, which plays a key role in insulin signaling. Recent studies have identified several polymorphisms in the human IRS-1 gene (Irs-1) that are increased in prevalence among type 2 diabetic patients. To determine whether variation in the Irs-1 contributes to genetic susceptibility to type 2 diabetes in Turkish people, PCR-RFLP and DNA sequencing method were utilized to analyze the coding region of Irs-1 in 70 subject and 116 control patients. Three missense mutations were detected (Gly972Arg, Ala512Pro, Ser892Gly). There was no significant association found with any of these variants and diabetes. The Gly972Arg mutation, however, was relatively more common in with 10/70 diabetic patients and 15/116 non-diabetic controls being heterozygous and 1/70 being and 0/116 non-diabetic controls being homozygous for this variant. As a conclusion, Ala512Pro, Ser892Gly mutations were rare and Met613Val, Ser1043Tyr and Cys1095Tyr mutations were not found in the populations studied. Gly972Arg is more common than other known mutations in our population but may not be a major determinant in genetic susceptibility to type 2 diabetes.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/diabetes-mellitus/molecular-scanning-for-mutations-in-the-insulin-receptor-substrate-1-irs-1-gene-in-turkish-with-type-2-diabetes-mellitus.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

